Jeffrey Szer (J Szer, Jeff Szer)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 76

Top Venues

Internal medicine journal

Bone marrow transplantation

Blood advances

Journal of clinical medicine

Royal Melbourne Hospital/VCCC

Monash University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Royal Melbourne Hospital/VCCC Aug 01 2016

Australia

Stream Lead :: Integrated Department of Haematology

Royal Melbourne Hospital Aug 01 2005 - Aug 01 2016

Australia

Professor/Director :: Clinical Haematology & BMT Service

Royal Melbourne Hospital Aug 01 1993 - Jul 31 2006

Australia

Head BMT Service :: Clinical Haematology & Medical Oncology

Education History

Monash University Dec 01 1976

Australia

BSC

Publications

Jeffrey Szer, Jens Panse, Austin Kulasekararaj, Monika Oliver, Bruno Fattizzo, Jun-Ichi Nishimura, Regina Horneff, Johan Szamosi, Régis Peffault de Latour
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function. International journal of molecular sciences 25 (16) (2024)
Paul A Komesaroff, Elizabeth L Potter, Emma R Felman, Jeffrey Szer
How should journals respond to the emerging challenges of artificial intelligence? Internal medicine journal (2024)
Régis Peffault de Latour, Morag Griffin, Richard J Kelly, Jeffrey Szer, Carlos M de Castro, Regina Horneff, Lisa Tan, Michael Yeh, Jens Peter Panse
Hemolysis events in the phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria. Blood advances 8 (11) (2024)
Jeffrey Szer
Donor safety confirmed. Blood advances 8 (15) (2024)
Jeffrey Szer
C5 inhibition in PNH: still effective and safe. Blood 143 (12) (2024)
Régis Peffault de Latour, Morag Griffin, Richard J Kelly, Jeffrey Szer, Carlos M de Castro, Regina Horneff, Lisa Tan, Michael Yeh, Jens Peter Panse
Hemolysis events in the phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria. Blood advances 8 (11) (2024)
Jeffrey Szer
The Journal in 2023. Internal medicine journal (2024)
Morag Griffin, Richard J Kelly, Jens Peter Panse, Carlos de Castro, Jeffrey Szer, Regina Horneff, Lisa Tan, Michael Yeh, Régis Peffault de Latour
Management of acute breakthrough hemolysis with intensive pegcetacoplan dosing in patients with PNH. Blood advances 8 (7) (2024)
Régis Peffault de Latour, Morag Griffin, Richard J Kelly, Jeffrey Szer, Carlos M de Castro, Regina Horneff, Lisa Tan, Michael Yeh, Jens Peter Panse
Hemolysis events in the phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria. Blood advances 8 (11) (2024)
Jeffrey Szer, Jens Panse, Austin Kulasekararaj, Monika Oliver, Bruno Fattizzo, Jun-Ichi Nishimura, Regina Horneff, Johan Szamosi, Régis Peffault de Latour
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function. International journal of molecular sciences 25 (16) (2024)
Régis Peffault de Latour, Morag Griffin, Richard J Kelly, Jeffrey Szer, Carlos M de Castro, Regina Horneff, Lisa Tan, Michael Yeh, Jens Peter Panse
Hemolysis events in the phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria. Blood advances 8 (11) (2024)
Jeffrey Szer
The Journal in 2023. Internal medicine journal 54 (1) (2024)
Jeffrey Szer
Donor safety confirmed. Blood advances 8 (15) (2024)
Morag Griffin, Richard J Kelly, Jens Peter Panse, Carlos de Castro, Jeffrey Szer, Regina Horneff, Lisa Tan, Michael Yeh, Régis Peffault de Latour
Management of acute breakthrough hemolysis with intensive pegcetacoplan dosing in patients with PNH. Blood advances 8 (7) (2024)
Lynette Chee, Nora Lee, Andrew Grigg, Melissa Chen, Anthony Schwarer, Jeffrey Szer, Sumita Ratnasingam, Sonia Raj, Pohan Lukito, David Yeung, Timothy Hughes, Naranie Shanmuganathan
Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in Australia. Internal medicine journal 54 (7) (2024)
Jeffrey Szer
Thrombosis in PNH: largely gone, but not forgotten. Blood 144 (2) (2024)
Morag Griffin, Richard J Kelly, Jens Peter Panse, Carlos DeCastro, Jeffrey Szer, Regina Horneff, Lisa Tan, Michael Yeh, Régis Peffault de Latour
Management of Acute Breakthrough Hemolysis with Intensive Pegcetacoplan Dosing in Patients with PNH. Blood advances (2024)
Régis Peffault de Latour, Morag Griffin, Richard J Kelly, Jeffrey Szer, Carlos M de Castro, Regina Horneff, Lisa Tan, Michael M Yeh, Jens Peter Panse
Hemolysis events in the Phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria. Blood advances (2024)
Jeffrey Szer
C5 inhibition in PNH: still effective and safe. Blood 143 (12) (2024)
Lynette Chee, Nora Lee, Andrew Grigg, Melissa Chen, Anthony Schwarer, Jeffrey Szer, Sumita Ratnasingam, Sonia Raj, Pohan Lukito, David Yeung, Timothy Hughes, Naranie Shanmuganathan
Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in Australia. Internal medicine journal (2024)
Jeffrey Szer
The Journal in 2023. Internal medicine journal 54 (1) (2024)
Jeffrey Szer
The Journal in 2022. Internal medicine journal 53 (1) (2023)
Ari Zimran, Jeffrey Szer, Michal Becker-Cohen, Sjoerd Jens, Claudia Cozma, Shoshana Revel-Vilk
The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy. Journal of clinical medicine 12 (6) (2023)
Ashlea Campbell, Benjamin W Teh, Stephen Mulligan, David M Ross, Robert Weinkove, Nicole Gilroy, Shane A Gangatharan, Henry Miles Prince, Jeffrey Szer, Judith Trotman, Steven Lane, Michael J Dickinson, Hang Quach, Anoop K Enjeti, Matthew Ku, Gareth Peter Gregory, Gregory Hapgood, Phoebe Joy Ho, Tara Cochrane, Chan Cheah, Matthew Greenwood, Maya Latimer, Leanne Berkahn, Joel Wight, Tasman Armytage, Peter Diamond, Constantine S Tam, Nada Hamad
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies. Internal medicine journal (2023)
Ashlea Campbell, Benjamin W Teh, Stephen Mulligan, David M Ross, Robert Weinkove, Nicole Gilroy, Shane A Gangatharan, Henry Miles Prince, Jeffrey Szer, Judith Trotman, Steven Lane, Michael J Dickinson, Hang Quach, Anoop K Enjeti, Matthew Ku, Gareth Peter Gregory, Gregory Hapgood, Phoebe Joy Ho, Tara Cochrane, Chan Cheah, Matthew Greenwood, Maya Latimer, Leanne Berkahn, Joel Wight, Tasman Armytage, Peter Diamond, Constantine S Tam, Nada Hamad
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies. Internal medicine journal 54 (2) (2023)
Gemma Mcerlean, Ashish Bajel, Abir Bhattacharyya, Ngaire Brown, Richard De Abreu Lourenco, Matthew Greenwood, Ian Kerridge, Nancy Kim, David Kliman, Della Maneze, Tracey O'Brien, Jeffrey Szer, Ida Twist
If we do not count it, it does not count: ethnicity in allogeneic haemopoietic stem cell transplant in Australia. Internal medicine journal (2023)
Michal Becker-Cohen, Shoshana Revel-Vilk, Dafna Frydman, Tama Dinur, Maayan Tiomkin, Majdolen Istaiti, Naama Arbel, Peter Bauer, Claudia Cozma, Arndt Rolfs, Jeffrey Szer, Ari Zimran
Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease. Internal medicine journal (2023)
Shirlene Sim, Anna Kalff, Gina Tuch, Peter Mollee, Joy Ho, Simon Harrison, Simon D J Gibbs, H Miles Prince, Andrew Spencer, Douglas Joshua, Cindy Lee, Silvia Ling, Nick Murphy, Ferenc Szabo, Jeffrey Szer, Nicholas Weber, Christopher Ward, Dipti Talaulikar, Andrew C W Zannettino, Hang Quach
The Importance of Frailty Assessment in Multiple Myeloma: A Position Statement From The Myeloma Scientific Advisory Group (MSAG) To Myeloma Australia. Internal medicine journal (2023)
Ari Zimran, Jeffrey Szer, Michal Becker-Cohen, Sjoerd Jens, Claudia Cozma, Shoshana Revel-Vilk
The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy. Journal of clinical medicine 12 (6) (2023)
Shoshana Revel-Vilk, Royston Mansfield, Neta Feder-Krengel, Noya Machtiger-Azoulay, David Kuter, Jeffrey Szer, Hanna Rosenbaum, David Cavalcanti Ferreira, Noa Ruhrman-Shahar, Michael P Wajnrajch, Ari Zimran
Real-World Experiences with Taliglucerase Alfa Home Infusions for Patients with Gaucher Disease: A Global Cohort Study. Journal of clinical medicine 12 (18) (2023)
Ari Zimran, Jeffrey Szer, Michal Becker-Cohen, Sjoerd Jens, Claudia Cozma, Shoshana Revel-Vilk
The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy. Journal of clinical medicine 12 (6) (2023)
Ashley McEwan, Matthew Greenwood, Christopher Ward, David Ritchie, Jeffrey Szer, Elizabeth Gardiner, Andriana Colic, Julija Sipavicius, Yvonne Panek-Hudson, Ian Kerridge
Diagnosis and management of endothelial disorders following haematopoietic stem cell transplantation. Internal medicine journal (2023)
Jeffrey Szer
The Journal in 2022. Internal medicine journal 53 (1) (2023)
Ashlea Campbell, Benjamin W Teh, Stephen Mulligan, David M Ross, Robert Weinkove, Nicole Gilroy, Shane A Gangatharan, Henry Miles Prince, Jeffrey Szer, Judith Trotman, Steven Lane, Michael J Dickinson, Hang Quach, Anoop K Enjeti, Matthew Ku, Gareth Peter Gregory, Gregory Hapgood, Phoebe Joy Ho, Tara Cochrane, Chan Cheah, Matthew Greenwood, Maya Latimer, Leanne Berkahn, Joel Wight, Tasman Armytage, Peter Diamond, Constantine S Tam, Nada Hamad
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies. Internal medicine journal 54 (2) (2023)
Majdolen Istaiti, Dafna Frydman, Tama Dinur, Jeffrey Szer, Shoshana Revel-Vilk, Ari Zimran
High-Dose Ambroxol Therapy in Type 1 Gaucher Disease Focusing on Patients with Poor Response to Enzyme Replacement Therapy or Substrate Reduction Therapy. International journal of molecular sciences 24 (7) (2023)
Jeffrey Szer
The Journal in 2022. Internal medicine journal 53 (1) (2023)
Louis Terriou, Jong Wook Lee, Cecily Forsyth, Morag Griffin, Jeffrey Szer, Alexander Röth, Philippe Gustovic, Jesse Metzger, Ami S Patel, Christopher Jordan Patriquin
Long-term effectiveness of eculizumab: Data from the International PNH Registry. European journal of haematology (2023)
Gérard Socie, Dietger Niederwieser, Nikolas von Bubnoff, Mohamad Mohty, Jeffrey Szer, Reuven Or, James Garrett, Anirudh Cadapa Prahallad, Celine Wilke, Robert Zeiser
Prognostic Value of Blood Biomarkers in Steroid-Refractory/Dependent Acute Graft-vs-Host Disease: A REACH2 Analysis. Blood (2023)
Calvin Gan, Patricia L Robertson, Jeffrey K C Lai, Jeffrey Szer
Fat fraction quantification of bone marrow in the lumbar spine using the LiverLab assessment tool in healthy adult volunteers and patients with Gaucher disease. Internal medicine journal (2022)
Michael J Shipton, Paul M Kinsella, Thomas Davis, Francesca Azzato, George Taiaroa, Jeffrey Szer, David Routledge, Olivia Smibert
Infective hyperammonaemic encephalopathy after allogeneic stem cell transplant. Bone marrow transplantation 57 (6) (2022)
Radha Ramanan, Andrew B M Lim, Joanne L C Tan, Rahul D Barmanray, Kate Mason, Jenny Collins, Matthew Hillman, Jeffrey Szer, Ashish Bajel, David Ritchie
Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft-versus-host disease prophylaxis following allogeneic haemopoietic cell transplantation. Internal medicine journal (2022)
Ashvind A Prabahran, Rachel M Koldej, Lynette Chee, Jeffrey Szer, David Ritchie
Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review. Bone marrow transplantation 57 (10) (2022)
Michal Becker-Cohen, Jeffrey Szer, Naama Arbel, Dafna Frydman, Tama Dinur, Majdolene Istaiti, Shoshana Revel-Vilk, Ari Zimran
Rapid velaglucerase alfa infusion for Gaucher disease: 5-year data. Internal medicine journal 52 (9) (2022)
Jeffrey Szer
The Journal in 2021. Internal medicine journal 52 (1) (2022)
Austin G Kulasekararaj, Axel Glasmacher, Peng Liu, Jeffrey Szer, David Araten, Geraldine Rauch, Chad Gwaltney, J Rafael Sierra, Jong Wook Lee
Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria. European journal of haematology 108 (5) (2022)
Katherine J Creeper, Bradley Augustson, Kieran Kusel, Michael J Fulham, Joy Ho, Hang Quach, Peter Mollee, Nicholas Weber, Dipti Talaulikar, Anna Johnston, Nick Murphy, Douglas Joshua, Christopher Ward, Silvia Ling, John Gibson, Jeffrey Szer, Simon Harrison, Andrew C W Zannettino, Wilfrid Jaksic, Cindy Lee, Andrew Spencer, Anna Kalff, Ferenc Szabo, Ken Romeril, Henry S H Chan, Simon D J Gibbs, Noemi Horvath, H Miles Prince
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma Australia. Internal medicine journal 51 (10) (2021)
Jeffrey Szer
The Journal in 2020. Internal medicine journal 51 (1) (2021)
Ian J Woolley, Daniel P Steinfort, Jeffrey Szer
COVID-19: looking backward. Internal medicine journal 51 (8) (2021)
Georgia J McCaughan, Pietro R Di Ciaccio, Michelle Ananda-Rajah, Nicole Gilroy, Raina MacIntyre, Benjamin Teh, Robert Weinkove, Jennifer Curnow, Jeffrey Szer, Anoop K Enjeti, David M Ross, Stephen Mulligan, Judith Trotman, Michael J Dickinson, Hang Quach, Philip Young-Ill Choi, Mark N Polizzotto, Constantine S Tam, P Joy Ho, Matthew Ku, Gareth Gregory, Shane Gangatharan, Gregory Hapgood, Tara Cochrane, Chan Cheah, Simon Gibbs, Andrew Wei, Anna Johnston, Matthew Greenwood, H Miles Prince, Maya Latimer, Leanne Berkahn, Joel Wight, Tasman Armytage, Nada Hamad
COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement. Internal medicine journal 51 (5) (2021)
Edward Robert Scheffer Cliff, Jeffrey Szer
We must grow the Australian Bone Marrow Donor Registry. Internal medicine journal 51 (11) (2021)
Purwa Joshi, Lynette Kiers, Andrew Howard Evans, David Ritchie, Jeffrey Szer, Belinda Cruse
Oromandibular parafunction in chronic graft-versus-host disease: novel association and treatment approach. Internal medicine journal 51 (11) (2021)
Ian Nivison-Smith, Ashish Bajel, Anthony J Dodds, David Gottlieb, Nada Hamad, Glen Kennedy, Ian Kerridge, D F David, Samuel Milliken, John Moore, Duncan Purtill, Jeffrey Szer
Effect of donor age on adult unrelated donor hematopoietic cell transplant outcome: the Australian experience. Internal medicine journal (2020)
Atul Mehta, David J Kuter, Sam S Salek, Nadia Belmatoug, Bruno Bembi, Jeremy Bright, Stephan Vom Dahl, Federica Deodato, Maja Di Rocco, Ozlem Göker-Alpan, Derralynn A Hughes, Elena A Lukina, David H Vesole, Eugen Mengel, Aabha Nagral, Kimitoshi Nakamura, Aya Narita, Beatriz Oliveri, Gregory Pastores, Jordi Pérez-López, Uma Ramaswami, Ida V Schwartz, Jeffrey Szer, Neal J Weinreb, Ari Zimran
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative. Internal medicine journal 49 (5) (2020)
Rohtesh S Mehta, Shernan G Holtan, Tao Wang, Michael T Hemmer, Stephen R Spellman, Mukta Arora, Daniel R Couriel, Amin M Alousi, Joseph Pidala, Hisham Abdel-Azim, Ibrahim Ahmed, Mahmoud Aljurf, Medhat Askar, Jeffery J Auletta, Vijaya Raj Bhatt, Christopher Bredeson, Saurabh Chhabra, Shahinaz M Gadalla, James Gajewski, Robert Peter Gale, Usama Gergis, Peiman Hematti, Gerhard C Hildebrandt, Yoshihiro Inamoto, Carrie Kitko, Pooja Khandelwal, Margaret L MacMillan, Navneet Majhail, David I Marks, Parinda Mehta, Taiga Nishihori, Richard F Olsson, Attaphol Pawarode, Miguel Angel Diaz, Tim Prestidge, Muna Qayed, Hemalatha Rangarajan, Olle Ringden, Ayman Saad, Bipin P Savani, Sachiko Seo, Ami Shah, Niketa Shah, Kirk R Schultz, Melhem Solh, Thomas Spitzer, Jeffrey Szer, Takanori Teshima, Leo F Verdonck, Kirsten M Williams, Baldeep Wirk, John Wagner, Jean A Yared, Daniel J Weisdorf
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. Blood advances 3 (9) (2020)
Ari Zimran, Jeffrey Szer, Shoshana Revel-Vilk
Impact of Gaucher disease on COVID-19. Internal medicine journal 50 (7) (2020)
Jeffrey Szer, Daniel Weisdorf, Sergio Querol, Lydia Foeken, Alejandro Madrigal
The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage. Bone marrow transplantation 55 (10) (2020)
Lucy Claire Fox, Michelle Tan, Anna L Brown, Peer Arts, Ella R Thompson, Georgina L Ryland, Jennifer Lickiss, Hamish S Scott, Nicola K Poplawski, Kerry Phillips, Neil A Came, Paul James, Stephen B Ting, David S Ritchie, Jeffrey Szer, Christopher N Hahn, Anthony Schwarer, Piers A Blombery
A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability. British journal of haematology 190 (5) (2020)
Jeffrey Szer
Is there no place like home for an allogeneic stem cell transplant? Bone marrow transplantation 55 (5) (2020)
Jeffrey Szer
The Journal in 2019. Internal medicine journal 50 (1) (2020)
Jeffrey Szer
COVID-19: looking forward. Internal medicine journal 50 (6) (2020)
Ibrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, Nicolaus Kroeger, Samir Agrawal, Marcelo C Pasquini, Yoshiko Atsuta, Karen K Ballen, Adriana Seber, Wael Saber, Mohamed A Kharfan-Dabaja, Walid Rasheed, Shinichiro Okamoto, Nandita Khera, William A Wood, Mickey B C Koh, Hildegard Greinix, Yoshihisa Kodera, Jeffrey Szer, Mary M Horowitz, Daniel Weisdorf, Mahmoud Aljurf
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries. Bone marrow transplantation 55 (4) (2019)
Jeffrey Szer
The Journal in 2018. Internal medicine journal 49 (1) (2019)
Danielle B Clucas, Lucy C Fox, Erica Michelle Wood, Frank S Hong, John Gibson, Ashish Bajel, Jeffrey Szer, Piers Blombery, Zoe K McQuilten, Devendra Hiwase, Frank Firkin, Merrole F Cole-Sinclair, null null
Revisiting acquired aplastic anaemia: current concepts in diagnosis and management. Internal medicine journal 49 (2) (2019)
Mahmoud Aljurf, Daniel Weisdorf, Feras Alfraih, Jeffrey Szer, Carlheinz Müller, Dennis Confer, Shahrukh Hashmi, Nicolaus Kröger, Bronwen E Shaw, Hildegard Greinix, Mohamed A Kharfan-Dabaja, Lydia Foeken, Adriana Seber, Syed Ahmed, Areej El-Jawahri, Moheeb Al-Awwami, Yoshiko Atsuta, Marcelo Pasquini, Amr Hanbali, Hazzaa Alzahrani, Shinichiro Okamoto, Eliane Gluckman, Mohamad Mohty, Yoshihisa Kodera, Mary Horowitz, Dietger Niederwieser, Riad El Fakih
"Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries". Bone marrow transplantation 54 (8) (2019)
Simon Pahnke, Torstein Egeland, Jörg Halter, Hans Hägglund, Bronwen E Shaw, Ann E Woolfrey, Jeffrey Szer, null null
Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation. Bone marrow transplantation 54 (6) (2018)
Antonio M Almeida, Camille Bedrosian, Alexander Cole, Petra Muus, Hubert Schrezenmeier, Jeffrey Szer, Wendell F Rosse
Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal Haemoglobinuria Registry. Internal medicine journal 47 (9) (2018)
Ari Zimran, Shoshana Revel-Vilk, Michal Becker-Cohen, Gaya Chicco, Naama Arbel, Arndt Rolfs, Jeffrey Szer
Rapid intravenous infusion of velaglucerase-alfa in adults with type 1 Gaucher disease. American journal of hematology 93 (9) (2018)
Oi Lin Lee, Noemi Horvath, Cindy Lee, Doug Joshua, Joy Ho, Jeffrey Szer, Hang Quach, Andrew Spencer, Simon Harrison, Peter Mollee, Andrew W Roberts, Dipti Talaulikar, Ross Brown, Bradley Augustson, Silvia Ling, Wilfrid Jaksic, John Gibson, Anna Kalff, Anna Johnston, Akash Kalro, Chris Ward, H Miles Prince, Andrew C W Zannettino
Bisphosphonate guidelines for treatment and prevention of myeloma bone disease. Internal medicine journal 47 (8) (2018)
Andrew B M Lim, Cameron Curley, Chun Y Fong, Ian Bilmon, Ashanka Beligaswatte, Duncan Purtill, Bartlomiej Getta, Anne M Johnston, Tasman Armytage, Marnie Collins, Kate Mason, Katherine Fielding, Matthew Greenwood, John Gibson, Mark Hertzberg, Matthew Wright, Ian Lewis, John Moore, David Curtis, Jeffrey Szer, Glen Kennedy, David Ritchie
Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse. Internal medicine journal 48 (3) (2018)
Helen Baldomero, Mahmoud Aljurf, Syed Z A Zaidi, Shahrukh K Hashmi, Ardeshir Ghavamzadeh, Alaa Elhaddad, Rose-Marie Hamladji, Parvez Ahmed, Lamia Torjemane, Miguel Abboud, Abdelghani Tbakhi, Murtadha Al Khabori, Asma El Quessar, Nosa Bazuaye, Mohamed Amine Bekadja, Salman Adil, Omar Fahmy, Mani Ramzi, Ahmed Ibrahim, Amal Alseraihy, Nour Ben Abdejalil, Mahmoud Sarhan, Mohammed Al Huneini, Lahoucine Mahmal, Hassan ElSolh, Fazal Hussain, Amr Nassar, Hani Al-Hashmi, Amir Ali Hamidieh, Marcelo Pasquini, Yoshihisa Kodera, Nicolaus Kröger, Mohamed Mohty, Gregorio Jaimovich, Juliana Martinez Rolon, Kristjan Paulson, Hildegard Greinix, Daniel Weisdorf, Mary Horowitz, José Nunez, Alois Gratwohl, Jacob Passweg, Mickey Koh, Jeffrey Szer, Dietger Niederwieser, Nicolas Novitzky, null null
Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends. Bone marrow transplantation 54 (3) (2018)
David Buchbinder, Debra Lynch Kelly, Rafael F Duarte, Jeffery J Auletta, Neel Bhatt, Michael Byrne, Zachariah DeFilipp, Melissa Gabriel, Anuj Mahindra, Maxim Norkin, Hélène M Schoemans, Ami J Shah, Ibrahim Ahmed, Yoshiko Atsuta, Grzegorz Władysław Basak, Sara Beattie, Sita Bhella, Christopher Bredeson, Nancy Bunin, Jignesh Dalal, Andrew Daly, James Gajewski, Robert Peter Gale, John Galvin, Mehdi Hamadani, Robert J Hayashi, Kehinde Adekola, Jason Law, Catherine J Lee, Jane Liesveld, Adriana K Malone, Arnon Nagler, Seema Naik, Taiga Nishihori, Susan K Parsons, Angela Scherwath, Hannah-Lise Schofield, Robert Soiffer, Jeffrey Szer, Ida Twist, Anne B Warwick, Baldeep M Wirk, Jean Yi, Minoo Battiwalla, Mary D E Flowers, Bipin Savani, Bronwen E Shaw
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone marrow transplantation 53 (5) (2018)
Eric Wong, Joanne E Davis, Andrew Grigg, Jeffrey Szer, David Ritchie
Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation. Bone marrow transplantation 54 (2) (2018)
Ian A Scott, Andrew McGavigan, Mark Ferson, Ian Woolley, Morton G Burt, Anthony Russell, Paul Bridgman, Joseph Ting, David Blacker, Yvonne Bonomo, Jennifer H Martin, Jeffrey Szer
Selected state of the art research in internal medicine, 2017. Internal medicine journal 48 (6) (2018)
L Chee, M Tacey, B Lim, A Lim, Jeffrey Szer, D Ritchie
Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation. Bone marrow transplantation 52 (6) (2017)
Jeffrey Szer
The Journal in 2016. Internal medicine journal 47 (1) (2017)
Jeffrey Szer
Could renal impairment be a positive predictor of outcome in autografts for myeloma? Bone marrow transplantation 51 (10) (2016)

Jeffrey Szer.css-eqlu8i{font-size:small;padding-left:4px;} (J Szer, Jeff Szer)

Publication Activity (10 Years)

Top Topics

Top Venues

Jeffrey Szer (J Szer, Jeff Szer)